NA
IMA

NewEdge Advisors’s ImageneBio Inc IMA Stock Holding History

NewEdge Advisors’s Portfolio IMA Stock Details IMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$800 Sell
160
-331
-67% -$2.15K ﹤0.01% 3930
2025
Q4 		$3.39K Sell
491
-12,469
-96% -$92.5K ﹤0.01% 3775
2025
Q3 		$106K Buy
+12,960
New +$172K ﹤0.01% 2587

Other funds holding IMA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

NewEdge Advisors's IMA Position: Q1 2026 in Review

NewEdge Advisors reduced its ImageneBio Inc (IMA) stake by 67% in Q1 2026, selling an estimated $2.15K and leaving 160 shares worth $800. The position accounts for ﹤0.01% of the portfolio, ranked #3930.

NewEdge Advisors first reported a position in IMA in Q3 2025 and has held it in 3 quarters since. The position peaked at $106K in Q3 2025. 39 funds tracked by Wall St. Rank hold IMA as of Q1 2026.

  • NewEdge Advisors held 160 shares of ImageneBio Inc worth $800 as of Q1 2026.
  • NewEdge Advisors sold 331 ImageneBio Inc shares in Q1 2026, an estimated $2.15K.
  • ImageneBio Inc made up ﹤0.01% of NewEdge Advisors's portfolio in Q1 2026, its #3930 holding.
  • NewEdge Advisors first reported a position in ImageneBio Inc in Q3 2025 and has held it in 3 quarters since.
  • NewEdge Advisors's ImageneBio Inc position peaked at $106K in Q3 2025.
  • 39 funds tracked by Wall St. Rank held ImageneBio Inc as of Q1 2026.

Based on NewEdge Advisors's 13F filing for Q1 2026, filed 18 May 2026.